Related Experiment Video
Updated: Jun 20, 2025

08:44
Assembly and Characterization of Polyelectrolyte Complex Micelles
Published on: March 2, 2020
10.7K
Nanoassemblies of Chitosan-Based Polyelectrolyte Complexes as Nucleic Acid Delivery Systems
Hussein H Genedy1, Thierry Delair1, Pierre Alcouffe1
1Université Claude Bernard Lyon 1, UMR 5223, CNRS, INSA Lyon, Université Jean Monnet, Ingénierie des Matériaux Polymères, F-69622 Villeurbanne, France.
Biomacromolecules
|July 18, 2024
Summary
Chitosan-dextran sulfate polyelectrolyte complexes form stable, sterilizable nanovectors for nucleic acid delivery. These biocompatible nanoassemblies offer a green and scalable platform for targeted gene therapy applications.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery
Background:
- Effective nucleic acid delivery necessitates vectorization for nuclease protection, immune evasion, and cellular targeting.
- Ideal nanovectors must be safe, manufacturable, and stable for clinical applications.
Purpose of the Study:
- To develop and characterize novel, biocompatible nanovectors for nucleic acid delivery using a green synthesis approach.
- To demonstrate the potential of chitosan-based polyelectrolyte complexes as versatile nanocarriers.
Main Methods:
- Utilized polyelectrolyte complexation of chitosan and dextran sulfate at 25 °C in water.
- Characterized nanoassemblies for size (20-35 nm), colloidal stability (>1 year), and steam sterilizability.
- Demonstrated encapsulation/adsorption of model nucleic acids and surface attachment of targeting agents.
Main Results:
- Green synthesis yielded stable nanoassemblies (20-35 nm) with long-term colloidal stability (>1 year).
- Nanovectors were steam sterilizable and capable of carrying nucleic acids via encapsulation or adsorption.
- Surface functionalization with targeting agents was successfully achieved.
Conclusions:
- Chitosan-based polyelectrolyte complexes represent a promising, biocompatible platform for nanovector development.
- The green synthesis process offers a scalable and safe method for producing stable nanocarriers.
- These nanovectors show potential for targeted nucleic acid delivery in therapeutic applications.

